Ever wanted to learn from some of the world’s experts on mobile devices and health technology? And apply it towards solving international health issues? Physicians from Stanford University will re-offer their online course, Mobile Health Without Borders, addressing these topics. Their course is available to the public at no charge.
June 16,2014. The DNA Medicine Insitute (DMI) announced today that it has been awarded a contract from NASA to develop non-invasive capabilities for the rHEALTH platform. This platform is based on technology to measure a plethora of values from a single drop of blood, bodily fluid. The reusable Handheld Electrolyte and Lab Technology for Humans (rHEALTH) sensor (http://catai.net/blog/2014/07/r-health-reusable-handheld-sensor/ ) is a compact portable device that employs cutting-edge fluorescence detection optics, innovative microfluidics, and nanostrip reagents to perform a suite of hematology, chemistry, and biomarker assays from a single drop of blood or bodily fluid.
Researchers at the University of California Santa Barbara (UCSB) are making rapid progress in designing a biosensor that can measure therapeutic levels of a prescription drug in real time within the patient. This technology has interesting implications for anatomic pathology and clinical laboratory testing.
The Institute of Medicine's Roundtable on Value & Science-Driven Health Care held a workshop, titled Partnering with Patients to Drive Shared Decisions, Better Value, and Care Improvement, on February 25 and 26, 2013. The workshop, supported by the Gordon and Betty Moore Foundation and the Blue Shield of California Foundation, focused on identifying and exploring issues, attitudes, and approaches to increasing patient engagement in and demand for the following: shared decision making and better communication about the evidence in support of testing and treatment options; the best value from the health care they receive; and the use of data ...
President Obama and Congress poured $30 billion in taxpayer subsidies for digital medical records beginning in 2009, with few strings attached and no safety oversight of the vendors who sell the systems. Although the explosion in use of the electronic records has opened up a new category of patient risks, the Obama administration has opted against mandatory reporting of problems.
A new study finds that electronic health record systems certified for meaningful use Stage 2 are not necessarily interoperable with other EHR systems. Researchers identified 11 trouble spots that prevent such interoperability and offered recommendations for overcoming such challenges. Bloomberg BNA's "Health Care Blog" et al.